CORTNE BENTON: Open Payments
NPI 1255848941 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 35 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $866 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| Novo Nordisk Inc | 7 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 1 | $71 |
| ABBVIE INC. | 2 | $51 |
| Lilly USA, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $20 |
Products named: CAPLYTA, AIRSUPRA, VOQUEZNA, FARXIGA, Auvelity, TRELEGY ELLIPTA, BREZTRI, UBRELVY.
Industry payments across AL — which companies pay providers there.
